English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Sickle Cell disease (SCD) is a chronic, inherited hemoglobin disorder associated with lifelong severe and life-threatening complications in neonates, pediatrics, and transitioning young adults (1). These chronic severe complications include anemia, episodic intense pains, stroke, priapism, infections, organ failure, tissue damage, increased morbidity, and premature death while transiting from pediatric to adults. The incapacitating episodic complications associated with the SCD limited the opportunities of those SCD patients in education, societal roles, career options, and quality of life (QoL) (2).

Health Care Transitions for Children with Sickle Cell Disease: Interventions, Perspectives of Health Care Providers and Caregivers